Locations:
Search IconSearch

Tag: cancer clinical trials

Dr. Ali and patient
January 29, 2026/Cancer/News & Insight

Real-World Data Reveals Gap Between Guidelines and Practice in HER2+ Breast Cancer Care

Standard of care is linked to better outcomes, but disease recurrence and other risk factors often drive alternative approaches

Dr. Mukhejee and colleagues
January 22, 2026/Cancer/News & Insight

Rare Cancers and Blood Disease Program Accelerates Diagnostic Journey

Multidisciplinary teams bring pathological and clinical expertise

CAR T-cell therapy
December 15, 2025/Cancer/Blood Cancers

Case Study: Patient Remains Disease Free Five Years After Allogenic CAR T-Cell Therapy

Patient with quadruple refractory multiple myeloma achieves complete response with cell therapy

Dr. Gerds
December 8, 2025/Cancer/News & Insight

AI Screening Platform Accelerates Trial Recruitment in Polycythemia Vera

AI-driven tools can streamline enrollment and improve efficiency across clinical trials.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

PET scan after CAR T-cell therapy
December 5, 2025/Cancer/Blood Cancers

Case Study: Overcoming Communication Barriers to Enroll Patient in CAR T-Cell Therapy Clinical Trial

Patient achieves complete remission from aggressive marginal zone lymphoma with liso-cel

World map
June 19, 2025/Cancer/News & Insight

Breaking Barriers to Cancer Care: Cleveland Clinic’s Global Approach

A multi-pronged strategy for tackling cancer access problems

CAR T-cell therapy illustration
June 12, 2025/Cancer/News & Insight

First-Ever U.S. Trial of CAR T-Cell Therapy for Relapsed/Refractory AL Amyloidosis

Early results show patients experiencing deep and complete response

rendering of Doxorubicin molecules
December 13, 2024/Cancer/News & Insight

Research Offers Further Insight into Chemo Scheduling for Early Breast Cancer

Phase 3 trial found no survival differences between weekly or biweekly doxorubicin/cyclophosphamide or between weekly or biweekly paclitaxel

Dr. Grobmyer and team
June 14, 2024/Cancer/Innovations

Fatima bint Mubarak Center Improves Access to Emerging Therapies and Clinical Trials

Cleveland Clinic Cancer Institute brings multidisciplinary care, precision oncology and clinical research to the United Arab Emirates

Physician with patient
February 21, 2024/Cancer/Research

Removing Barriers to Clinical Trial Access

Cleveland Clinic Cancer Institute takes multi-faceted approach to ensuring clinical trials representation

BackPage 1 of 2Next

Advertisement

Ad